Phase II trial of oxaliplatin plus oral capecitabine as first-line chemotherapy for patients with advanced gastric cancer
Aims and background The efficacy of chemotherapy for advanced gastric cancer is now widely accepted. However, the survival advantage is small, and no internationally accepted standard regimen has emerged. The present study investigated the efficacy and safety of oxaliplatin plus oral capecitabine (X...
Saved in:
Published in | Tumori Vol. 97; no. 4; pp. 466 - 472 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London, England
SAGE Publications
01.07.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!